João Rudolfo Kleinübing

Dr. João Rudolfo Kleinübing

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MTMatheus Hideki Taborda
Matheus Hideki Taborda
JKJoão Rudolfo Kleinübing
João Rudolfo Kleinübing
DLDiego Ricardo Lodi Lauriano
Diego Ricardo Lodi Lauriano
JSJoão Victor de Oliveira Souza
João Victor de Oliveira Souza
LKLeonardo Kami
Leonardo Kami
BTBernardo Correa de Almeida Teixeira
Bernardo Correa de Almeida Teixeira
Central nervous system (CNS) lymphoproliferative disorders comprise a heterogeneous group of rare entities that present major diagnostic and therapeutic challenges. Primary CNS large B-cell lymphoma (LBCL) is the most common form and the second most frequent primary CNS tumor after gliomas. The 5th edition of the World Health Organization Classification of Hematolymphoid Tumours introduced updated terminology, including primary LBCL of immune-privileged sites and lymphomas arising in immunodeficiency/dysregulation, along with less common variants such as intravascular large B-cell lymphoma, lymphomatoid granulomatosis, lymphomatosis cerebri, secondary CNS lymphoma, mucosa-associated lymphoid tissue (MALT) lymphoma of the dura, and T-cell/NK-cell lymphomas. Immune status, Epstein–Barr virus association, and imaging features may assist differentiation, although biopsy remains essential for definitive diagnosis. On MRI, lesions are typically periventricular or involve the basal ganglia, showing low T2 signal intensity, restricted diffusion, and intense enhancement. Spectroscopy demonstrates elevated choline/N-acetylaspartate ratios with lipids, and perfusion is generally lower than in other neoplasms. Corticosteroid administration before biopsy should be avoided due to potential cytolysis of tumor cells. Major differential diagnoses include glioblastoma, metastases, demyelinating lesions, and infections such as toxoplasmosis, fungal abscess, and tuberculosis. Treatment may cause neurotoxicity and immunosuppression, predisposing patients to opportunistic infections.